Trial Details
COMPLETEDBasic Information
| Clinical ID | c1821 |
|---|---|
| Identifier | NCT02694588 |
| Trial Title | Clinical and Molecular Phenotyping in IBD |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | IBD |
| Interventions | DRUG: Infliximab; DRUG: Vedolizumab |
Participant Information
| Sponsor | University Hospital Schleswig-Holstein |
|---|---|
| City | Kiel |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2025-06-14 |
|---|---|
| Primary Completion Date | 2025-10-18 |
| Completion Date | 2025-12-21 |